{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:06:49Z","timestamp":1781896009808,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.jsbmb.2003.10.004","type":"journal-article","created":{"date-parts":[[2004,2,7]],"date-time":"2004-02-07T05:16:18Z","timestamp":1076130978000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Selective non-steroidal inhibitors of 5\u03b1-reductase type 1"],"prefix":"10.1016","volume":"88","author":[{"given":"Ernesto G.","family":"Occhiato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Guarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Danza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Serio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2003.10.004_BIB1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0165-6147(89)90048-5","article-title":"Inhibitors of steroid 5\u03b1-reductase in benign prostatic hyperplasia","volume":"10","author":"Metcalf","year":"1989","journal-title":"Trends. Pharm. Sci."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB2","unstructured":"D.A. Holt, M.A. Levy, B.W. Metcalf, Inhibition of steroid 5\u03b1-reductase, in: B.E. Maryanoff, C.A. Maryanoff (Eds.), Advances in Medicinal Chemistry, vol. 2, JAI Press Inc., Greenwich, USA, 1993, pp. 1\u201329."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/0929867302666220217000031","article-title":"Steroidal and non-steroidal inhibitors of steroid 5\u03b1-reductase","volume":"2","author":"Abell","year":"1995","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0039-128X(95)00021-H","article-title":"The enzyme and inhibitors of 4-ene-3-oxosteroid 5\u03b1-oxidoreductase","volume":"60","author":"Li","year":"1995","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1381612802666220920215559","article-title":"Inhibitors of 5\u03b1-reductase","volume":"2","author":"Frye","year":"1996","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1021\/jm960697s","article-title":"Pharmacological options in the treatment of benign prostatic hyperplasia","volume":"40","author":"Kenny","year":"1997","journal-title":"J. Med. Chem."},{"issue":"5\/6","key":"10.1016\/j.jsbmb.2003.10.004_BIB7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0039-128X(98)00020-8","article-title":"5-alpha-reductase inhibitors, chemical and clinical models","volume":"63","author":"Guarna","year":"1998","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.bi.63.070194.000325","article-title":"Steroid 5\u03b1-reductases: two genes\/two enzymes","volume":"63","author":"Russell","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB9","first-page":"577","article-title":"Steroid 5\u03b1-reductase 2 deficiency","volume":"14","author":"Wilson","year":"1993","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB10","first-page":"179","article-title":"Chemical control of androgen action","volume":"22","author":"Rasmusson","year":"1986","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI116665","article-title":"Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression","volume":"92","author":"Thigpen","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0015-0282(98)00094-6","article-title":"Regional distribution of 5alpha-reductase type 1 and type 2 mRNA along the human epididymis","volume":"69","author":"Mahony","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2133.1999.03042.x","article-title":"Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp","volume":"141","author":"Bayne","year":"1999","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.jsbmb.2003.10.004_BIB14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-2133.1999.03156.x","article-title":"Expression of m-RNA for androgen receptor, 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase in human dermal papilla cells","volume":"141","author":"Ando","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-0760(98)00030-2","article-title":"The 5alpha-reductase in the central nervous system: expression and modes of control","volume":"65","author":"Melcangi","year":"1998","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0960-0760(95)00167-0","article-title":"Kinetic analysis of steroid 5alpha-reductase activity at neutral pH in benign prostatic hyperplastic tissue: evidence for type I isozyme activity in the human prostate","volume":"57","author":"Span","year":"1996","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB17","first-page":"3160","article-title":"The biochemical and phenotypic characterization of females homozygous for 5\u03b1-reductase-2 deficency","volume":"80","author":"Katz","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2003.10.004_BIB18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJM199401133300208","article-title":"Finasteride","volume":"330","author":"Rittmaster","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2003.10.004_BIB19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00003495-199957040-00008","article-title":"Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia","volume":"57","author":"Wilde","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00365599950509997","article-title":"Finasteride in the treatment of benign prostatic hypertrophy: an update. New indications for finasteride therapy","volume":"203","author":"Ekman","year":"1999","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"issue":"3","key":"10.1016\/j.jsbmb.2003.10.004_BIB21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"ARIA3001, ARIA3002 and ARIA3003 study investigators, efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.jsbmb.2003.10.004_BIB22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2003.10.004_BIB23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocrine Rev."},{"issue":"12","key":"10.1016\/j.jsbmb.2003.10.004_BIB24","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1210\/jcem.86.12.8078","article-title":"Production rates of dihydrotestosterone in healthy men and women and in men with male pattern baldness: determination by stable isotope\/dilution and mass spectrometry","volume":"86","author":"Vierhapper","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5\/6","key":"10.1016\/j.jsbmb.2003.10.004_BIB25","first-page":"243","article-title":"The hair follicle: a paradoxical androgen target organ","volume":"54","author":"Randall","year":"2000","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB26","doi-asserted-by":"crossref","unstructured":"Finasteride male pattern hair loss study group, long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia, Eur. J. Dermatol. 12(1) (2002) 38\u201349.","DOI":"10.33589\/12.3.0129"},{"issue":"4","key":"10.1016\/j.jsbmb.2003.10.004_BIB27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0015-0282(02)04927-0","article-title":"Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism","volume":"79","author":"Lumachi","year":"2003","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jsbmb.2003.10.004_BIB28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/ror.0.0040179","article-title":"Male and female isoenzymes of steroid 5alpha-reductase","volume":"4","author":"Mahendroo","year":"1999","journal-title":"Rev. Reprod."},{"issue":"5","key":"10.1016\/j.jsbmb.2003.10.004_BIB29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","article-title":"Cutaneous androgen metabolism: basic research and clinical perspectives","volume":"119","author":"Chen","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB30","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1021\/jm00378a028","article-title":"Azasteroids as inhibitors of rat prostatic 5 alpha-reductase","volume":"27","author":"Rasmusson","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB31","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1021\/jm00161a028","article-title":"Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding","volume":"29","author":"Rasmusson","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB32","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1021\/ja953069t","article-title":"Mechanism-based inhibition of human steroid 5\u03b1-reductase by finasteride: enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bi-substrate analog inhibitor","volume":"118","author":"Bull","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB33","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1021\/jm00078a022","article-title":"6-Azasteroids: potent dual inhibitors of human type 1 and 2 steroid 5 alpha-reductase","volume":"36","author":"Frye","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB34","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1021\/jm00041a014","article-title":"6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase\/3-keto-delta 5-steroid isomerase","volume":"37","author":"Frye","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1021\/jm960807v","article-title":"19-nor-10-Azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2","volume":"40","author":"Guarna","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB36","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1021\/jm970297k","article-title":"19-nor-10-Azasteroids, a new class of steroid 5 alpha-reductase inhibitors. 2. X-ray structure, molecular modeling, conformational analysis of 19-nor-10-azasteroids and comparison with 4-azasteroids and 6-azasteroids","volume":"40","author":"Guarna","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB37","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/jo971917s","article-title":"A concise route to 19-Nor-10-azasteroids, a new class of steroid 5\u03b1-reductase inhibitors. 3.1 synthesis of (+)-19-nor-10-azatestosterone and (+)-17\u03b2-(acetyloxy)-(5\u03b2)-10-azaestr-1-en-3-one","volume":"63","author":"Guarna","year":"1998","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB38","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1016\/S0040-4020(98)00678-4","article-title":"Stereoselectivity in the TiCl4-catalysed reaction of Danishefsky\u2019s diene with a N-(acyloxy)iminium ion: synthesis of 5\u03b1 versus 5\u03b2\u0394 1(2)-19-nor-10-azasteroids 4","volume":"54","author":"Occhiato","year":"1998","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB39","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1021\/jo990373m","article-title":"19-Nor-10-azasteroids. 5.(1) a synthetic strategy for the preparation of (+)-17-(3-pyridyl)-(5beta)-10-azaestra-1,16-dien-3-one, a novel potential inhibitor for human cytochrome P450(17)(alpha) (17alpha-hydroxylase\/C(17,20)-lyase)","volume":"64","author":"Guarna","year":"1999","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0960-0760(94)90145-7","article-title":"Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5\u03b1-reductase isoform 2","volume":"48","author":"Levy","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB41","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1021\/jo00099a031","article-title":"Improved syntheses of epristeride, a potent human 5 alpha-reductase inhibitor","volume":"59","author":"Baine","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB42","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/jm00165a010","article-title":"Inhibition of steroid 5 alpha-reductase by unsaturated 3-carboxysteroids","volume":"33","author":"Holt","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB43","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1021\/bi00463a026","article-title":"Inhibition of rat liver steroid 5 alpha-reductase by 3-androstene-3-carboxylic acids: mechanism of enzyme\u2013inhibitor interaction","volume":"29","author":"Levy","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB44_1","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1021\/ja953069t","article-title":"Mechanism-based inhibition of human steroid 5\u03b1-reductase by finasteride: enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bi-substrate analog inhibitor","volume":"118","author":"Bull","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB44_2","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1021\/bi00041a024","article-title":"Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies","volume":"34","author":"Tian","year":"1995","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.jsbmb.2003.10.004_BIB45","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1021\/jm00049a003","article-title":"4,7 beta-Dimethy-l-4-azacholestan-3-one (MK-386) and related 4-azasteroids as selective inhibitors of human type 1 5alpha-reductase","volume":"37","author":"Bakshi","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB46","unstructured":"H. Nakai, H. Terashima, Y. Arai, International Patent Application EP 0 291245 A2, Nov 17, 1988."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB47","unstructured":"H. Nakai, H. Terashima, Y. Arai, Benzylaminophenoxybutanoic acid derivatives as drugs for acne, alopecia, prostatic hypertrophy, their preparation, and formulations containing them, Chem. Abstr. 110:708 (212384t)."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/jm00396a013","article-title":"New potent antagonists of leukotrienes C4 and D4. 1. synthesis and structure-activity relationships","volume":"31","author":"Nakai","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/jm00055a014","article-title":"Non-steroidal inhibitors of human type I steroid 5-alpha-reductase","volume":"36","author":"Jones","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB50","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0960-894X(00)80306-6","article-title":"QSAR study of benzoquinolinones as inhibitors of human type 1 5-\u03b1-reductase","volume":"3","author":"Wikel","year":"1993","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB51","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0960-894X(01)80363-2","article-title":"Preparative chiral HPLC separation of all possible stereoisomers of LY191704 and LY266111 and their in vitro inhibition of human types 1 and 2 steroid 5\u03b1-reductases","volume":"4","author":"Abell","year":"1994","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0960-894X(98)00035-3","article-title":"Synthesis and 5\u03b1-reductase inhibitory activity of 8-substituted benzo[f]quinolinones derived from palladium mediated coupling reactions","volume":"8","author":"Smith","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB53","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0960-894X(00)00368-1","article-title":"Simple Bi- and tricyclic inhibitors of human steroid 5\u03b1-reductase","volume":"10","author":"Abell","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1521-4184(20005)333:5<145::AID-ARDP145>3.0.CO;2-Q","article-title":"New non-steroidal steroid 5 alpha-reductase inhibitors: syntheses and structure-activity studies on carboxamide phenylalkyl-substituted pyridones and piperidones","volume":"333","author":"Hartmann","year":"2000","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB55","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0223-5234(94)90104-X","article-title":"Novel 5 alpha reductase inhibitors: synthesis and structure-activity studies of 5-substituted 1-methyl-2-pyridones and 1-methyl-2-piperidones","volume":"29","author":"Hartmann","year":"1994","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0928-0987(94)90111-2","article-title":"FC2 5\u03b1-reductase inhibitors: synthesis and structure-activity studies on new non-steroidal compounds","volume":"2","author":"G\u00f6ring","year":"1994","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0223-5234(00)01167-3","article-title":"6-Substituted 1H-quinolin-2-ones and 2-methoxy-quinolines: synthesis and evaluation as inhibitors of steroid 5alpha reductases types 1 and 2","volume":"35","author":"Baston","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1071\/C97130","article-title":"The preparation and biological activity of lactam-based, non-steroidal inhibitors of human type-1 steroid 5\u03b1-reductase","volume":"51","author":"Abell","year":"1998","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB59","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1016\/0040-4039(95)00690-E","article-title":"Synthesis of phenanthridin-3-one derivatives: non-steroidal inhibitors of steroid 5-\u03b1-reductase","volume":"36","author":"Mook","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB60","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/jm000945r","article-title":"Benzo[c]quinolizin-3-ones: a novel class of potent and selective non-steroidal inhibitors of human steroid 5alpha-reductase 1","volume":"43","author":"Guarna","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB61","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/S0960-894X(98)00505-8","article-title":"Synthesis of benzo[c]quinolizin-3-ones: selective non-steroidal inhibitors of steroid 5 alpha-reductase 1","volume":"8","author":"Guarna","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0960-894X(99)00698-8","article-title":"Synthesis of 8-chloro-benzo[c]quinolizin-3-ones as potent and selective inhibitors of human steroid 5alpha-reductase 1","volume":"10","author":"Guarna","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB63","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1021\/jm00049a003","article-title":"4,7 beta-Dimethyl-4-azacholestan-3-one (MK-386) and related 4-azasteroids as selective inhibitors of human type 1 5 alpha-reductase","volume":"37","author":"Bakshi","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB64","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0968-0896(01)00012-8","article-title":"Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selective inhibitors of human 5 alpha-reductase 1","volume":"9","author":"Guarna","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0960-0760(01)00022-X","article-title":"Structure-function studies of human 5-alpha reductase type 2 using site directed mutagenesis","volume":"77","author":"Baxter","year":"2001","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB66","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0960-894X(96)00054-6","article-title":"A comparison of steroidal and non-steroidal inhibitors of human steroid 5\u03b1-reductase: new tricyclic aryl acid inhibitors of the type-1 isozyme","volume":"6","author":"Abell","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1521-4184(20007)333:7<201::AID-ARDP201>3.0.CO;2-D","article-title":"5 alpha-reductase in intact DU145 cells: evidence for isozyme I and evaluation of novel inhibitors","volume":"333","author":"Reichert","year":"2000","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB68","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0960-894X(99)00234-6","article-title":"N-substituted 4-(5-indolyl)benzoic acids: synthesis and evaluation of steroid 5\u03b1-reductase type I and II inhibitory activity","volume":"9","author":"Baston","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1248\/cpb.48.382","article-title":"A novel class of inhibitors for human steroid 5alpha-reductase: synthesis and biological evaluation of indole derivatives. II","volume":"48","author":"Igarashi","year":"2000","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB70","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1248\/cpb.47.226","article-title":"Synthesis of 2-phenylbenzofuran derivatives as testosterone 5 alpha-reductase inhibitor","volume":"47","author":"Ishibashi","year":"1999","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0960-894X(98)00001-8","article-title":"Synthesis and 5\u03b1-reductase inhibitory activities of benzofuran derivatives with a carbamoyl group","volume":"8","author":"Ishibashi","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB72","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0960-894X(96)00261-2","article-title":"The development of non-steroidal dual inhibitors of both human 5\u03b1-reductase isozymes","volume":"6","author":"Blagg","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.jsbmb.2003.10.004_BIB73","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1097-0045(19980215)34:3<222::AID-PROS10>3.0.CO;2-G","article-title":"Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate","volume":"34","author":"Span","year":"1998","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.jsbmb.2003.10.004_BIB74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1097-0045(19991201)41:4<224::AID-PROS2>3.0.CO;2-Q","article-title":"5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3","volume":"41","author":"Negri-Cesi","year":"1999","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.jsbmb.2003.10.004_BIB75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0960-0760(96)00020-9","article-title":"Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells","volume":"58","author":"Kaefer","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.jsbmb.2003.10.004_BIB76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1097-0045(19980301)34:4<283::AID-PROS6>3.0.CO;2-I","article-title":"Presence of 5alpha-reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue","volume":"34","author":"Negri-Cesi","year":"1998","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.jsbmb.2003.10.004_BIB77","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1747.2001.01312.x","article-title":"Sebocytes are the key regulators of androgen homeostasis in human skin","volume":"116","author":"Fritsch","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"23","key":"10.1016\/j.jsbmb.2003.10.004_BIB78","doi-asserted-by":"crossref","first-page":"17404","DOI":"10.1016\/S0021-9258(19)85349-8","article-title":"Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes","volume":"268","author":"Thigpen","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jsbmb.2003.10.004_BIB79","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0960-0760(96)00050-7","article-title":"MK386: a potent, selective inhibitor of the human type 1 5alpha-reductase","volume":"58","author":"Ellsworth","year":"1996","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(98)00059-4","article-title":"Cloning, expression and characterization of rhesus macaque types 1 and 2 5alpha-reductase: evidence for mechanism-based inhibition by finasteride","volume":"66","author":"Ellsworth","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0960-0760(94)00183-M","article-title":"Cloning, expression and functional characterization of type 1 and type 2 steroid 5alpha-reductases from cynomolgus monkey: comparisons with human and rat isoenzymes","volume":"52","author":"Levy","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB82","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1097-0045(20000801)44:3<233::AID-PROS8>3.0.CO;2-C","article-title":"Partial sequencing and tissue distribution of the canine isoforms of steroid 5alpha-reductase type I and type II","volume":"44","author":"Span","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB83","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/0888-7543(91)90038-G","article-title":"Characterization and chromosomal mapping of a human steroid 5alpha-reductase gene and pseudogene and mapping of the mouse homologue","volume":"11","author":"Jenkins","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.jsbmb.2003.10.004_BIB84","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1073\/pnas.87.10.3640","article-title":"Structural and biochemical properties of cloned and expressed human and rat steroid 5alpha-reductases","volume":"87","author":"Andersson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007600300503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007600300503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:46:05Z","timestamp":1760733965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007600300503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S096007600300503X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2003.10.004","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective non-steroidal inhibitors of 5\u03b1-reductase type 1","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2003.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}